Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | ALPL | P05186 | 2/20 | 0.38 |
| ▸ | ALPG | P10696 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALPI | P09923 | 1/20 | 0.38 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.34 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1165059 | 0.85 | FDPS (0.39) | FDPSALDH1A1KMT2AALPLALPG | |
| SCHEMBL7017228 | 0.83 | ALDH1A1 (0.41) | ALDH1A1ALPLALPGALPIPLAA | |
| SCHEMBL298299 | 0.83 | — | — | |
| SCHEMBL9502453 | 0.83 | — | — | |
| SCHEMBL446875 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL16433303 | 0.79 | PARP1 (0.42) | FDPSALDH1A1KMT2AALPLALPG | |
| SCHEMBL14825913 | 0.78 | LPO (0.44) | FDPSKMT2AALPLALPGALPI | |
| SCHEMBL8761396 | 0.78 | FDPS (0.39) | FDPSALDH1A1KMT2AALPLALPG | |
| SCHEMBL13114302 | 0.78 | FDPS (0.39) | FDPSALDH1A1KMT2AALPLALPG | |
| SCHEMBL13134140 | 0.78 | ALDH1A1 (0.41) | FDPSALDH1A1KMT2AALPLALPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624129-B2 | Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking thereof | BMG PHARMA S.P.A. (IT) | 2026-05-12 | — | — | US | claimed |
| US-20220411541-A1 | CROSSLINKED BUTYRATE OR BUTYRATE-FORMATE DERIVATIVES OF HYALURONIC ACID AND THE CROSSLINKING THEREOF | BMG PHARMA S.P.A. (IT) | 2022-12-29 | — | — | US | claimed |
| EP-3507320-B1 | USE OF AN ORGANOCARBONATE MODIFIED PRE-POLYMER AS AN EDUCT FOR THE PRODUCTION OF ISOCYANATE-FREE AND ISOTHIOCYANATE-FREE ALKOXYSILANE POLYMERS | MERZ BENTELI AG (CH) | 2020-10-21 | — | — | EP | claimed |
| US-20190352461-A1 | USE OF AN ORAGANOCARBONATE-MODIFIED PREPOLYMER AS REACTANT FOR PREPARATION OF ISOCYANATE-FREE AND ISOTHIOCYANATE-FREE ALKOXYSILANE POLYMERS | MERZ+BENTELI AG (CH) | 2019-11-21 | — | — | US | claimed |
| EP-2558441-B1 | PROCESS FOR PRODUCING ISOCYANATES | 3M INNOVATIVE PROPERTIES CO (US) | 2018-05-30 | — | — | EP | claimed |
| EP-2909177-B1 | PROCESS FOR PREPARING ROFLUMILAST | INTERQUIM SA (ES) | 2017-03-29 | — | — | EP | claimed |
| US-9321726-B2 | Process for preparing roflumilast | INTERQUIM, S.A. (ES) | 2016-04-26 | — | — | US | claimed |
| US-20150246884-A1 | PROCESS FOR PREPARING ROFLUMILAST | INTERQUIM, S.A. (ES) | 2015-09-03 | — | — | US | claimed |
| US-9006480-B2 | Process for producing isocyanates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-04-14 | — | — | US | claimed |
| US-20130023694-A1 | PROCESS FOR PRODUCING ISOCYANATES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-01-24 | — | — | US | claimed |
| EP-2377847-A1 | Process for producing isocyanates | 3M Innovative Properties Company (US) | 2011-10-19 | — | — | EP | claimed |
| WO-2008023383-A1 | NOVEL PROCESS FOR THE PREPARATION OF TELITHROMYCIN | ALEMBIC LIMITED (IN) | 2008-02-28 | — | — | WO | claimed |
| US-20080051352-A1 | Novel process for the preparation of telithromycin | ALEMBIC LIMITED (IN) | 2008-02-28 | — | — | US | claimed |
| EP-0004570-B1 | THIOL ESTERS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND A PROCESS FOR PREPARING CEPHALOSPORIN COMPOUNDS USING THE SAME | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1982-04-14 | — | — | EP | claimed |
| EP-0004570-A1 | Thiol esters, process for their preparation, pharmaceutical compositions containing them and a process for preparing cephalosporin compounds using the same | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1979-10-17 | — | — | EP | claimed |
| US-12624129-B2 | Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking thereof | BMG PHARMA S.P.A. (IT) | 2026-05-12 | — | — | US | disclosed |
| EP-4161580-B1 | CANNABINOID-HYALURONIC ACID BIOCONJUGATES | LONDON PHARMACEUTICALS AND RES CORPORATION (CA) | 2026-03-18 | — | — | EP | disclosed |
| US-3992409-A | ANTICOLINERGIC AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-11-16 | — | — | US | disclosed |
| US-3984397-A | CYCLIZATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-10-05 | — | — | US | disclosed |
| US-3954732-A | BACTERICIDAL PENICILLINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051352-A1 | Novel process for the preparation of telithromycin | TREH, CYP3A7, CYP3A4 | FDPS 219/4885ALDH1A1 4146/4885KMT2A 3599/4885 |
| US-12624129-B2 | Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking thereof | CD44, MUC1, FGB | FDPS 248/4885ALDH1A1 340/4885KMT2A 3443/4885 |
| US-20130023694-A1 | PROCESS FOR PRODUCING ISOCYANATES | IDH2, IDH1, IDH3A | FDPS 39/4885ALDH1A1 313/4885KMT2A 878/4885 |
| US-20150246884-A1 | PROCESS FOR PREPARING ROFLUMILAST | ESD, DNTT, HPD | FDPS 388/4885ALDH1A1 212/4885KMT2A 1021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.